Analyst Moves: ONXX, NOK, HON - Presented by: The Aol. On Network

This morning, Deutsche Bank downgraded shares of Onyx Pharmaceuticals (ONXX) from buy to hold as any acquisition would likely come around these levels, leaving less upside for investors. With the downgrade, Deutsche Bank set a $140 price target.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.24 0.11 ▲ 0.68%
FB $ 59.61 0.11 ▼ 0.18%
GE $ 26.72 0.60 ▲ 2.30%
QQQ $ 86.54 0.36 ▲ 0.42%
CSCO $ 23.17 0.14 ▲ 0.61%
MU $ 23.91 1.43 ▲ 6.36%
MSFT $ 40.12 0.28 ▼ 0.69%
HBAN $ 9.20 0.11 ▼ 1.18%

As of 4/17/2014, 01:53 PM
More Most Active